Portfolio company
HelixNano
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This biotechnology company develops messenger RNA technologies and vaccines for patients with infectious diseases, cancer, and organ transplant needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Helix Nanotechnologies
This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.
Helex
This biotechnology company develops gene editing therapeutics and lipid nanoparticle delivery platforms for patients suffering from genetic kidney diseases.
Strand Therapeutics
This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Immunohelix
Immunohelix develops immune cell-specific oligonucleotide delivery systems and therapeutics for pharmaceutical companies seeking targeted treatments for immunological diseases, infections, and cancers.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Strand Tx
Strand Tx develops programmable messenger RNA therapeutics for patients with cancer and autoimmune diseases.
